Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Neuromyelitis optica spectrum disease characteristics in Isfahan, Iran: A cross-sectional study.

Ashtari F, Safaei A, Shaygannejad V, Najafi MA, Vesal S.

J Res Med Sci. 2017 Mar 15;22:41. doi: 10.4103/1735-1995.202142. eCollection 2017.

2.

Clinically Isolated Syndromes: Clinical Characteristics, Differential Diagnosis, and Management.

Efendi H.

Noro Psikiyatr Ars. 2015 Dec;52(Suppl 1):S1-S11. doi: 10.5152/npa.2015.12608. Epub 2015 Dec 1. Review.

3.

Stability and predictive value of anti-JCV antibody index in multiple sclerosis: A 6-year longitudinal study.

Hegen H, Auer M, Bsteh G, Di Pauli F, Plavina T, Walde J, Deisenhammer F, Berger T.

PLoS One. 2017 Mar 20;12(3):e0174005. doi: 10.1371/journal.pone.0174005. eCollection 2017.

4.

Targeted treatment of brainstem neurohistiocytosis guided by urinary cell-free DNA.

Hunt D, Milne P, Fernandes P, Bigley V, Collin M.

Neurol Neuroimmunol Neuroinflamm. 2016 Nov 3;4(1):e299. eCollection 2017 Jan.

5.

Two Cases of Acute Disseminated Encephalomyelitis Following Vaccination Against Human Papilloma Virus.

Sekiguchi K, Yasui N, Kowa H, Kanda F, Toda T.

Intern Med. 2016;55(21):3181-3184. Epub 2016 Nov 1.

6.

The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study.

Solomon AJ, Bourdette DN, Cross AH, Applebee A, Skidd PM, Howard DB, Spain RI, Cameron MH, Kim E, Mass MK, Yadav V, Whitham RH, Longbrake EE, Naismith RT, Wu GF, Parks BJ, Wingerchuk DM, Rabin BL, Toledano M, Tobin WO, Kantarci OH, Carter JL, Keegan BM, Weinshenker BG.

Neurology. 2016 Sep 27;87(13):1393-9. doi: 10.1212/WNL.0000000000003152. Epub 2016 Aug 31.

PMID:
27581217
7.

Post-traumatic acute disseminated encephalomyelitis.

Magazi D, Wynand-Ndlovu L, Legwara P, Matlala B, Sebiloane S, Patel J.

Radiol Case Rep. 2015 Dec 7;7(3):584. doi: 10.2484/rcr.v7i3.584. eCollection 2012.

8.

"Central vessel sign" on 3T FLAIR* MRI for the differentiation of multiple sclerosis from migraine.

Solomon AJ, Schindler MK, Howard DB, Watts R, Sati P, Nickerson JP, Reich DS.

Ann Clin Transl Neurol. 2015 Dec 16;3(2):82-7. doi: 10.1002/acn3.273. eCollection 2016 Feb.

9.

MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines.

Filippi M, Rocca MA, Ciccarelli O, De Stefano N, Evangelou N, Kappos L, Rovira A, Sastre-Garriga J, Tintorè M, Frederiksen JL, Gasperini C, Palace J, Reich DS, Banwell B, Montalban X, Barkhof F; MAGNIMS Study Group..

Lancet Neurol. 2016 Mar;15(3):292-303. doi: 10.1016/S1474-4422(15)00393-2. Epub 2016 Jan 26. Review.

10.

Analysis of Lymphocytic DNA Damage in Early Multiple Sclerosis by Automated Gamma-H2AX and 53BP1 Foci Detection: A Case Control Study.

Rasche L, Heiserich L, Behrens JR, Lenz K, Pfuhl C, Wakonig K, Gieß RM, Freitag E, Eberle C, Wuerfel J, Dörr J, Bauer P, Bellmann-Strobl J, Paul F, Roggenbuck D, Ruprecht K.

PLoS One. 2016 Jan 28;11(1):e0147968. doi: 10.1371/journal.pone.0147968. eCollection 2016.

11.

Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis.

Traboulsee A, Simon JH, Stone L, Fisher E, Jones DE, Malhotra A, Newsome SD, Oh J, Reich DS, Richert N, Rammohan K, Khan O, Radue EW, Ford C, Halper J, Li D.

AJNR Am J Neuroradiol. 2016 Mar;37(3):394-401. doi: 10.3174/ajnr.A4539. Epub 2015 Nov 12.

12.

Quality improvement in neurology: Multiple sclerosis quality measures: Executive summary.

Rae-Grant A, Bennett A, Sanders AE, Phipps M, Cheng E, Bever C.

Neurology. 2015 Nov 24;85(21):1904-8. doi: 10.1212/WNL.0000000000001965. Epub 2015 Sep 2. Review. No abstract available.

13.

Metabolic dysfunctions in multiple sclerosis: implications as to causation, early detection, and treatment, a case control study.

Senanayake VK, Jin W, Mochizuki A, Chitou B, Goodenowe DB.

BMC Neurol. 2015 Aug 27;15:154. doi: 10.1186/s12883-015-0411-4.

14.

Oligoclonal Bands in Cerebrospinal Fluid of Black Patients with Multiple Sclerosis.

da Gama PD, Machado Ldos R, Livramento JA, Gomes HR, Adoni T, Morales Rde R, da Gama RA, da Gama DA, Lana-Peixoto MA, Fragoso YD, Callegaro D.

Biomed Res Int. 2015;2015:217961. doi: 10.1155/2015/217961. Epub 2015 Jul 29.

15.

Update on biomarkers in neuromyelitis optica.

Melamed E, Levy M, Waters PJ, Sato DK, Bennett JL, John GR, Hooper DC, Saiz A, Bar-Or A, Kim HJ, Pandit L, Leite MI, Asgari N, Kissani N, Hintzen R, Marignier R, Jarius S, Marcelletti J, Smith TJ, Yeaman MR, Han MH, Aktas O, Apiwattanakul M, Banwell B, Bichuetti D, Broadley S, Cabre P, Chitnis T, De Seze J, Fujihara K, Greenberg B, Hellwig K, Iorio R, Jarius S, Klawiter E, Kleiter I, Lana-Peixoto M, Nakashima, O'Connor K, Palace J, Paul F, Prayoonwiwat N, Ruprecht K, Stuve O, Tedder T, Tenembaum S, Garrahan JP, Aires B, van Herle K, van Pelt D, Villoslada P, Waubant E, Weinshenker B, Wingerchuk D, Würfel J, Zamvil S.

Neurol Neuroimmunol Neuroinflamm. 2015 Jul 23;2(4):e134. doi: 10.1212/NXI.0000000000000134. eCollection 2015 Aug. Review.

16.

Central Nervous System Idiopathic Inflammatory Demyelinating Disorders in South Americans: A Descriptive, Multicenter, Cross-Sectional Study.

Papais-Alvarenga RM, Vasconcelos CC, Carra A, de Castillo IS, Florentin S, Diaz de Bedoya FH, Mandler R, de Siervi LC, Pimentel ML, Alvarenga MP, Alvarenga MP, Grzesiuk AK, Gama Pereira AB, Gomes Neto AP, Velasquez C, Soublette C, Fleitas CV, Diniz DS, Armas E, Batista E, Hernandez F, Pereira FF, Siqueira HH, Cabeça H, Sanchez J, Brooks JB, Gonçalves MV, Barroso MC, Ravelo ME, Castillo MC, Ferreira ML, Rocha MS, Parolin MK, Molina O, Marinho PB, Christo PP, Brant de Souza R, Pessanha Neto S, Camargo SM, Machado SC, Neri VC, Fragoso YD, Alvarenga H, Thuler LC.

PLoS One. 2015 Jul 29;10(7):e0127757. doi: 10.1371/journal.pone.0127757. eCollection 2015.

17.

Neuromyelitis optica and neuromyelitis optica spectrum disorder: Natural history and long-term outcome, an Indian experience.

Jagtap SA, Mandliya A, Sarada C, Nair MD.

J Neurosci Rural Pract. 2015 Jul-Sep;6(3):331-5. doi: 10.4103/0976-3147.158755.

18.

Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis.

Absinta M, Vuolo L, Rao A, Nair G, Sati P, Cortese IC, Ohayon J, Fenton K, Reyes-Mantilla MI, Maric D, Calabresi PA, Butman JA, Pardo CA, Reich DS.

Neurology. 2015 Jul 7;85(1):18-28. doi: 10.1212/WNL.0000000000001587. Epub 2015 Apr 17.

19.

Demyelinating and thrombotic diseases of the central nervous system: common pathogenic and triggering factors.

Koudriavtseva T, Renna R, Plantone D, Mainero C.

Front Neurol. 2015 Mar 24;6:63. doi: 10.3389/fneur.2015.00063. eCollection 2015. Review. No abstract available.

20.

Optimizing multiple sclerosis diagnosis: gene expression and genomic association.

Gurevich M, Miron G, Achiron A.

Ann Clin Transl Neurol. 2015 Mar;2(3):271-7. doi: 10.1002/acn3.174. Epub 2015 Feb 6.

Supplemental Content

Support Center